Market closed
Conmed/$CNMD
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Conmed
Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgeries. The firm currently reports through two reporting units, orthopedic surgery, and general surgery. From a geographic perspective, the firm is U.S.-centric, with maximum domestic sales accounting for revenue, EMEA accounting for second place, APAC at third, and the non-U.S. Americas region driving the remaining revenue.
Ticker
$CNMD
Sector
Trading on
NYSE
Industry
Health Care Equipment & Supplies
Headquarters
Employees
4,000
Website
Conmed Metrics
BasicAdvanced
$2B
15.31
$4.25
1.47
$0.80
1.23%
Price and volume
Market cap
$2B
Beta
1.47
52-week high
$88.60
52-week low
$61.05
Average daily volume
447K
Dividend rate
$0.80
Financial strength
Total debt to equity
100.848
Interest coverage (TTM)
4.49%
Management effectiveness
Return on equity (TTM)
14.99%
Valuation
Price to earnings (TTM)
15.308
Price to revenue (TTM)
1.535
Price to book
2.15
Price to tangible book (TTM)
-4.02
Dividend yield (TTM)
1.23%
Forward dividend yield
1.23%
Growth
Revenue change (TTM)
5.00%
Earnings per share change (TTM)
108.33%
3-year revenue growth (CAGR)
8.95%
3-year earnings per share growth (CAGR)
29.88%
What the Analysts think about Conmed
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Conmed stock.
Conmed Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Conmed Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Conmed News
AllArticlesVideos
CONMED Corporation (CNMD) Q4 2024 Earnings Call Transcript
Seeking Alpha·1 week ago
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
Business Wire·1 month ago
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
Business Wire·3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Conmed stock?
Conmed (CNMD) has a market cap of $2B as of February 13, 2025.
What is the P/E ratio for Conmed stock?
The price to earnings (P/E) ratio for Conmed (CNMD) stock is 15.31 as of February 13, 2025.
Does Conmed stock pay dividends?
Yes, the Conmed (CNMD) stock pays dividends to shareholders. As of February 13, 2025, the dividend rate is $0.8 and the yield is 1.23%. Conmed has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Conmed dividend payment date?
The next Conmed (CNMD) dividend payment date is unconfirmed.
What is the beta indicator for Conmed?
Conmed (CNMD) has a beta rating of 1.47. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.